A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors von Schlechter, Benjamin L., Olson, Daniel, George, Mridula Annette, Saibil, Sam, Giordano, Antonio, Bouvier, Riemke, Gavriliuc, Miriam, Pieke, Brooke, Gruber, Kelly, Lichtenstein, Emily, Apostolopoulou, Maria, Moss, Kara M., Ternus, Nathan, Adib, Deyaa R, Dumbrava, Ecaterina Elena

Volltext

A phase I/II trial investigating the safety and efficacy of autologous TAC T cells targeting HER2 in relapsed or refractory solid tumors von Schlechter, Benjamin L., Olson, Daniel, Saibil, Samuel, George, Mridula Annette, Gruber, Kelly, Bouvier, Riemke, Pieke, Brooke, Geisburger, Jill, Moss, Kara M., Ternus, Nathan, Adib, Deyaa R, Dumbrava, Ecaterina Elena

Volltext

Targeting CNS Lymphoma with Intravenous Axicabtagene Ciloleucel: Evidence for Transcriptional Evolution Towards a Prominent Interferon Signature in CAR-T Cells Trafficking to the T... von Gerdemann, Ulrike, Kaminski, James, Albanese, Alexandre, Keskula, Paula, Cagnin, Lorenzo, Betz, Kayla, Zavistaski, Jillian, Fleming, Ryan A, Falvey, Caroline, Bouvier, Riemke, Jones, Julia, Poddar, Soumya, Mattie, Mike, Chukwueke, Ugonma, Torres, Alexandra, Jacobson, Caron A., Nayak, Lakshmi, Kean, Leslie S.

Volltext

A Pilot Study of Axicabtagene Ciloleucel (axi-cel) for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphoma (CNSL) von Jacobson, Caron A., Falvey, Caroline, Bouvier, Riemke, Hogan, Sarah, Kendricken, Elizabeth, Jones, Julia, Grimm, Elizabeth, Redd, Robert A., Lee, Eudocia Q, Gonzalez Castro, Luis, Chukwueke, Ugonma, McFaline Figueroa, Jose, Kim, Austin I., Torres, Alexandra, Ramsdell, Linda, Kean, Leslie S., Gerdemann, Ulrike, Albanese, Alexandre, Keskula, Paula, Meredith, David, Sholl, Lynette, Poddar, Soumya, Davis, Madison, Mao, Daquin, Filosto, Simone, Mattie, Mike, Armand, Philippe, Nayak, Lakshmi

Volltext

CTIM-37. A PILOT STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSED/REFRACTORY PRIMARY AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL AND SCNSL) von Nayak, Lakshmi, Falvey, Caroline, Bouvier, Riemke, Chukwueke, Ugonma, Hogan, Sarah, Kendricken, Elizabeth, Meehan, Christopher, Redd, Robert, Fisher, Jennifer, Torres, Alexandra, Jones, Julia, Lee, Eudocia, Kim, Austin, Castro, Luis Nicolas Gonzalez, McFaline-Figueroa, Jose Ricardo, Aquilanti, Elisa, Youssef, Gilbert, Arrillaga-Romany, Isabel, Murakami, Mark, Sholl, Lynette, Meredith, David, Huang, Raymond Y, Ramsdell, Linda, Gerdemann, Ulrike, Keskula, Paula, Kaminski, Jim, Albanese, Alexandre, Bi, Wenya Linda, Arnaout, Omar, Reardon, David, Wen, Patrick, Poddar, Soumya, Mao, Daqin, Mattie, Mike, Davis, Madison, Filosto, Simone, Kean, Leslie, Armand, Philippe, Jacobson, Caron

Volltext

760 A phase I/II trial investigating safety and efficacy of autologous TAC T cells targeting HER2 in relapsed or refractory solid tumors von Schlechter, Benjamin, Olson, Daniel, Saibil, Samuel, George, Mridula, Bouvier, Riemke, McKinley, Jessica, Pieke, Brooke, Geisburger, Jill, Ternus, Nathan, Moss, Kara, Adib, Deyaa, Dumbrava, Ecaterina

Volltext

Abstract CT234: A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors von Dumbrava, Ecaterina Elena, Olson, Daniel, Saibil, Samuel, Pieke, Brooke, George, Mridula A., Bouvier, Riemke, Gavriliuc, Miriam, Gruber, Kelly, Moss, Kara, Ternus, Nathan, Apostolopoulou, Maria, Adib, Deyaa, Schlechter, Benjamin L.

Volltext